CRL

#822
Charles River Laboratories International, Inc.
178.4900
+3.97%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
178.3500
179.8200
Годовой диапазон
146.4900
228.8800
Дневное изменение
+3.97%
Месячное изменение
-18.64%
6-месячное изменение
-9.33%
Годовое изменение
-9.33%
Предыдущее закрытие
171.6800
Open
178.6900
Bid
Ask
Low
178.3500
High
179.8200
Объем
820
Open full chart

Financials

Overview Отчетность Statistics Dividends
Quarterly Annual
  • Market Capitalization 8.8467 B
  • Employee 20 K
  • Founded N/A
  • CEO James C. Foster
  • Website www.criver.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000BG5BL8
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-69.81
Price to sales ratio
2.51
Dividends per share
—
Dividend yield %
—

Charles River Laboratories International Inc

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients. Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs. As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL.

Новости